DR-01 is a high affinity, fully human, nonfucosylated antibody that binds to a cell
surface receptor selectively expressed on cytotoxic cells which have been aberrantly proliferated in a
variety of NK and T-cell disorders. Upon binding, DR-01 induces fratricide of these malignant cells
via antibody-dependent cellular cytotoxicity (“ADCC”).